| 1 | Case | 1.24% | |
| 2 | Study | 1.16% | |
| 3 | Cancer | 1.16% | |
| 4 | Report | 1.16% | |
| 5 | Patients | 1.09% | |
| 6 | Disease | 0.87% | |
| 7 | New | 0.87% | |
| 8 | ASCO | 0.73% | |
| 9 | Risk | 0.66% | |
| 10 | May | 0.66% | |
| 11 | Treatment | 0.58% | |
| 12 | HIV | 0.51% | |
| 13 | According | 0.51% | |
| 14 | AI | 0.51% | |
| 15 | Health | 0.51% | |
| 16 | Carcinoma | 0.44% | |
| 17 | Use | 0.36% | |
| 18 | Gene | 0.36% | |
| 19 | Research | 0.36% | |
| 20 | Obesity | 0.36% | |
| 21 | Syndrome | 0.36% | |
| 22 | Cell | 0.36% | |
| 23 | Review | 0.29% | |
| 24 | Renal | 0.29% | |
| 25 | Rare | 0.29% | |
| 26 | U.S. | 0.29% | |
| 27 | Advanced | 0.29% | |
| 28 | Patient | 0.29% | |
| 29 | Linked | 0.29% | |
| 30 | Therapy | 0.29% | |
| 31 | Dysfunction | 0.29% | |
| 32 | Long-Term | 0.29% | |
| 33 | Potential | 0.29% | |
| 34 | Recurrent | 0.29% | |
| 35 | Heart | 0.29% | |
| 36 | Retrospective | 0.29% | |
| 37 | Clinical | 0.29% | |
| 38 | ADHD | 0.29% | |
| 39 | Trial | 0.29% | |
| 40 | Immune | 0.22% | |
| 41 | Status | 0.22% | |
| 42 | Outcomes | 0.22% | |
| 43 | Reconstruction | 0.22% | |
| 44 | Association | 0.22% | |
| 45 | Secondary | 0.22% | |
| 46 | Cervical | 0.22% | |
| 47 | CDC | 0.22% | |
| 48 | Primary | 0.22% | |
| 49 | Better | 0.22% | |
| 50 | Beyond | 0.22% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Cureus
2025-06-01 13:19:28
Examining Tominersen as a Potential Treatment for Huntington Disease: The GENERATION HD2 trial
NeurologyLive
2025-06-01 04:02:21
Electronic consent demonstrates potential to overcome “key barrier” in stroke trial recruitment
NeuroNews International
2025-06-01 02:18:09
UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer
FirstWord Pharma
2025-05-31 06:37:20
Zoledronic Acid in the Treatment of Primary Knee Osteoarthritis: A Randomized Clinical Trial
Cureus
2025-05-30 22:54:29